NeuroOne Medical Technologies (NMTC) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkyAI (SKYA) has outperformed NeuroOne Medical Technologies (NMTC) over the past year, losing 23.0% versus a loss of 82.9%. SkyAI is the larger company by market cap ($7.8 million vs $5.9 million), about 1.3 times the size. NeuroOne Medical Technologies converts more of its revenue into profit, with a net margin of -39.6% versus -138400.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMTC | SKYA |
|---|---|---|
| Share price | $0.6521 | $2.18 |
| Market cap | $5.94M | $7.82M |
| 1-day change | -3.38% | -45.50% |
| YTD return | -85.66% | +7.39% |
| 1-year return | -82.91% | -22.97% |
| 5-year return | -95.19% | — |
| P/E ratio (TTM) | — | 2.83 |
| EPS (TTM) | $-0.99 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $9.10M | $204.12K |
| Revenue growth (YoY) | +163.47% | — |
| Net income (latest FY) | $-3.61M | $-282.50M |
| Gross margin | 56.51% | -202.49% |
| Operating margin | -46.46% | -132145.49% |
| Net margin | -39.63% | -138400.02% |
| 52-week high | $6.12 | $4.39 |
| 52-week low | $0.61 | $0.91 |
| Distance from 52-week high | -89.34% | -50.34% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1014.86% | — |
| Average volume | 337.67K | 1.74M |
| Shares outstanding | 9.11M | 3.59M |
| Employees | 18 | 30 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKYA has outperformed NMTC by 59.9 percentage points over the past year.
- NeuroOne Medical Technologies is more profitable, keeping -39.6 cents of every revenue dollar as net income versus -138400.0 cents for SkyAI.
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Health Care · Medical/Dental Instruments · 18 employees
About SkyAI
SKYA stock →SkyAI, Inc., a financial technology company with a Solana digital asset treasury that is building an agentic finance platform. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa.
Health Care · Medical/Dental Instruments · 30 employees
NMTC vs SKYA FAQ
Which is bigger, NeuroOne Medical Technologies or SkyAI?
SkyAI (SKYA) is larger, with a market capitalization of $7.82M compared with $5.94M for NeuroOne Medical Technologies (NMTC).
Which stock has performed better over the past year, NMTC or SKYA?
SKYA returned -22.97% over the past 12 months, compared with -82.91% for NMTC (price return, excluding dividends). Past performance does not predict future results.
Are NeuroOne Medical Technologies and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.